✦ LIBER ✦
Nefis' sales revenue up 43%
- Publisher
- Elsevier Science
- Year
- 2010
- Weight
- 62 KB
- Volume
- 2010
- Category
- Article
- ISSN
- 1351-4210
No coin nor oath required. For personal study only.
✦ Synopsis
net sales of €245 M (€209 M for its 1Q 2009) and recurring EBITDA of €38 M (€14 M). Novecare reported significant improvement in profit driven by increased activity (volumes up by 18% year-on-year) across all regions, particularly in Asia. Volumes in the Industrial and the Agrochemical markets enjoyed a strong recovery. The Oilfield chemicals business is progressively recovering quarter after quarter. In 2Q 2010, Novecare should continue to deliver good performance.